Literature DB >> 4099842

Further observations on the ultrastructure and chemistry of the formation of asbestos bodies.

J M Davis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4099842     DOI: 10.1016/0014-4800(70)90096-1

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


× No keyword cloud information.
  8 in total

1.  Histochemical demonstration of hematoidin in the innermost layers of human asbestos body coating.

Authors:  M Governa; C R Vadalà
Journal:  Int Arch Arbeitsmed       Date:  1972

Review 2.  Assessment of mineral fibres from human lung tissue.

Authors:  J M Davis; B Gylseth; A Morgan
Journal:  Thorax       Date:  1986-03       Impact factor: 9.139

Review 3.  The pathology of asbestos related disease.

Authors:  J M Davis
Journal:  Thorax       Date:  1984-11       Impact factor: 9.139

4.  Asbestos body formation and iron accumulation in mouse peritoneal granulomas after the introduction of crocidolite asbestos fibers.

Authors:  H K Koerten; J Hazekamp; M Kroon; W T Daems
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

5.  Iron associated with asbestos bodies is responsible for the formation of single strand breaks in phi X174 RFI DNA.

Authors:  L G Lund; M G Williams; R F Dodson; A E Aust
Journal:  Occup Environ Med       Date:  1994-03       Impact factor: 4.402

Review 6.  Asbestos and other ferruginous bodies: their formation and clinical significance.

Authors:  A M Churg; M L Warnock
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

Review 7.  Morphological and chemical mechanisms of elongated mineral particle toxicities.

Authors:  Ann E Aust; Philip M Cook; Ronald F Dodson
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

8.  The Secretory Response of Rat Peritoneal Mast Cells on Exposure to Mineral Fibers.

Authors:  Violetta Borelli; Elisa Trevisan; Vita Francesca; Giuliano Zabucchi
Journal:  Int J Environ Res Public Health       Date:  2018-01-10       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.